The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMMO.L Regulatory News (IMMO)

  • There is currently no data for IMMO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Site opening and update

24 Mar 2021 07:00

RNS Number : 2562T
Immotion Group PLC
24 March 2021
 

24 March 2021

Immotion Group plc

 

("Immotion", the "Company" or the "Group")

 

Site opening and update

 

Immotion Group, the UK-based immersive entertainment group, is pleased to announce that its 22-seat 'Undersea Explorer' theatre opened last weekend, 21 March, at Clearwater Marine Aquarium in Florida. Footfall at the aquarium was strong and the early uptake of our installation was very encouraging. 

 

In the USA, the majority of the Company's Location-Based Entertainment ("LBE") partner sites are now open and trading as Covid related restrictions are beginning to ease. We are seeing an improving picture in the USA as we enter spring break and expect to see this continue into the Easter period.

 

In addition, we are very pleased to confirm that from 15 March 2021, capacity restrictions in Nevada, where our largest installation at Shark Reef Aquarium, Las Vegas, is based have now been relaxed. Permitted capacity is now back at 50%, the level which applied when we opened the site in August 2020. We are hopeful that this will improve further towards the summer months if restrictions are lifted further. 

 

Our "Tower Coaster" installation opened at Sydney Tower Eye on 5 March 2021, giving us three sites in Australia, all of which are fully open.

 

We expect to have the large majority of our LBE sites in USA and UK trading in the summer (with UK sites expected to re-open on 17 May 2021). We also expect a small number of new sites to open ahead of the UK/USA summer.

 

Our Home-Based Entertainment product, 'Let's Explore Oceans', was soft launched into the USA during the first week of March 2021, with initial orders being fulfilled from the UK. We are pleased to report that early sales have been encouraging. We will be increasing our USA-focused marketing activity and will, from early April 2021, be fulfilling USA demand from our fulfilment partner in Wisconsin, USA.

 

Uvisan continues to make steady progress with the new 'Cleanroom by Uvisan' product currently undergoing third-party lab certification.

 

A detailed update on current trading and prospects, which will cover the US spring break and Easter periods, along with our full year results for 2020, will be issued on 29 April 2021.

 

 

Martin Higginson, Immotion Group CEO said: "With new sites opening to encouraging footfall, the USA and UK on a pathway back to normality, and Australia fully open we are beginning to see the green shoots of recovery."

 

"Early sales of the 'Let's Explore Oceans' product in the USA have got off to a good start, and we now have the stock and logistics in place to accelerate the growth potential in this key market."

 

"The combination of a recovered Location Based Entertainment business with solid summer-time revenues, along with the Home Based offering, which we believe will see peak sales in Q4, has the makings of a well-balanced business."

 

"We look forward to updating the market further on our plans, along with a detailed trading update on 29th April 2021."

 

 For further information please visit www.immotion.co.uk, or contact: 

 

Immotion Group

 

Martin Higginson

David Marks

 

Tel + 44 (0) 207 220 1666

WH Ireland Limited

(Nomad and Joint Broker)

 

 

Adrian Hadden 

Darshan Patel

Matthew Chan

Tel + 44 (0) 207 220 1666

Alvarium Capital Partners

(Joint Broker)

Alex Davies

Tel: +44 (0) 207 195 1458

 

Shard Capital Partners LLP

(Co-Broker)

Damon Heath

Erik Woolgar

 

Tel: +44 (0) 20 7186 9900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDKNBKDBKBANB
Date   Source Headline
1st Mar 20237:00 amRNSCompletion of LBE Sale
28th Feb 20237:00 amRNSTotal Voting Rights
21st Feb 202311:13 amRNSResult of General Meeting
8th Feb 20233:24 pmRNSExercise of Options and TVR
2nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20232:00 pmRNSPrice Monitoring Extension
2nd Feb 202311:05 amRNSSecond Price Monitoring Extn
2nd Feb 202311:00 amRNSPrice Monitoring Extension
2nd Feb 20239:06 amRNSSecond Price Monitoring Extn
2nd Feb 20239:00 amRNSPrice Monitoring Extension
2nd Feb 20237:05 amRNSShare Buy back
2nd Feb 20237:02 amRNSProposed disposal of LBE and Notice of GM
2nd Feb 20237:00 amRNSMaster Agreement
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20222:05 pmRNSSecond Price Monitoring Extn
1st Dec 20222:00 pmRNSPrice Monitoring Extension
13th Oct 20227:00 amRNSImmotion signs two further Zoo Partners
30th Sep 20224:40 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20222:05 pmRNSSecond Price Monitoring Extn
30th Sep 20222:00 pmRNSPrice Monitoring Extension
30th Sep 202211:05 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim results for the six months to 30 June 2022
13th Sep 20227:00 amRNSChange of Adviser
18th Aug 20227:00 amRNSPre-Close Trading Update
30th Jun 20222:41 pmRNSResult of AGM
30th Jun 20227:00 amRNSAGM Trading Update
16th Jun 20227:00 amRNSChinese Aquarium Licensing Deal
1st Jun 20221:26 pmRNSNotice of AGM
19th May 20227:00 amRNS54 month - 40 Seat VR Theatre Deal Signed
6th May 20224:41 pmRNSSecond Price Monitoring Extn
6th May 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20227:00 amRNSFirst Major Zoo Agreement for Gorilla Trek
26th Apr 20227:00 amRNS2021 audited full year results and Company update
11th Apr 20227:00 amRNSNew Sites, Trading Update and date of Results
21st Feb 20227:00 amRNSShark Reef Aquarium & Trading Update
16th Dec 20217:00 amRNSTrading Update
30th Nov 20218:36 amRNSGrant of Options
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:35 pmRNSPrice Monitoring Extension
16th Nov 20212:00 pmRNSImmotion Launches VR Experience, ‘Gorilla Trek’
29th Sep 20213:57 pmRNSPDMR Dealing and Holding(s) in Company
28th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
23rd Sep 20217:00 amRNSInterim Results and Investor Presentation
15th Sep 202112:00 pmRNSNotice of Interim Results & Change of Address
16th Aug 20217:00 amRNSH1 outcome and July trading update
3rd Aug 20217:00 amRNSSEA LIFE Installation & Clearwater Extension
14th Jul 20217:00 amRNSUvisan signs distributor deals

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.